Search
AusCann says it is transitioning to a pharmaceutical production and sales business.

AusCann appoints CEO

Medical cannabis company AusCann Group Holdings has appointed international pharmaceutical executive Ido Kanyon as its new chief executive, nearly five months after it was announced that Elaine Darby would resign from the role.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

BN30 Index

Index = 100 as of 4 Jan 2016
Source: Morningstar

Top 10 Shareholders

Substantial shareholders as published in the annual report.
Source: Morningstar

Total Shareholder Return as at 30/09/19

1 year TSR5 year TSR
95thStrategic Elements83%5%
122ndRBR Group62%7%
764thAusCann Group Holdings-65%36%
829thIntiger Group-80%-28%
733 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

08/03/19
$11k Bought
07/03/19
$47k Bought
09/08/18
$15k Issued
Total value as at the date of the transaction
Source: Morningstar

Revenue

152nd↑AusCann Group Holdings$671k
153rd↑Intiger Group$572k
155th↓RBR Group$530k
156th↑Strategic Elements$515k
197 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer